The North America Pediatric Perfusion Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).
The latest developments in pediatric perfusion underline a shared commitment to the safety and quality of care for pediatric cardiac patients. Perfusionists, in close partnership with healthcare teams, are continually striving to refine their techniques, employ cutting-edge technologies, and explore innovative procedures to ensure the best possible outcomes. Moreover, stringent safety protocols and quality assurance measures are integral to pediatric perfusion. Perfusionists are required to adhere to meticulous standards, including those set forth by organizations such as the American Board of Cardiovascular Perfusion (ABCP) and the American Association for Thoracic Surgery (AATS). These organizations provide certification, guidelines, and educational resources to ensure that perfusionists are well-equipped to provide safe and effective care to pediatric patients.
Furthermore, in addition to oxygenators, cannulae have also undergone significant changes. Pediatric-specific cannulae are designed to be smaller and more flexible, allowing for easier access to the heart and ensuring that blood is returned to the circulatory system as smoothly as possible. The demand for pediatric perfusion is not limited to the optimization of existing techniques; it also embraces emerging methods and procedures that hold promise for improving patient outcomes. One notable development is the utilization of extracorporeal life support (ECLS) in pediatric cardiac surgery.
In the United States, a growing number of children are born with congenital heart defects, making it one of the leading causes of congenital disabilities in the country. Early diagnosis and improved awareness of congenital heart defects have resulted in an increased demand for pediatric cardiac surgeries and related perfusion services. Parents and caregivers are increasingly seeking specialized care to ensure the best possible outcomes for their children, contributing to the surge in demand for pediatric perfusion services. As the need for these services continues to grow, the market in the North America region will grow as well.
The US market dominated the North America Pediatric Perfusion Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $226,490.9 Thousands by 2030. The Canada market is registering a CAGR of 7.5% during (2023 - 2030). Additionally, The Mexico market would showcase a CAGR of 6.6% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Cardiac Centers, and Others. Based on Product, the market is segmented into Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps, Pediatric Arterial Filters, Monitoring Systems and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Pediatric Perfusion Market is Predict to reach $801.8 Million by 2030, at a CAGR of 5.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.
By End Use
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 